TCM
MRSN icon

Tekla Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Tekla Capital Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-6,495
Closed -$667K – 176
2023
Q1 		$667K Buy
+6,495
New +$667K 0.03% 140